Erlotinib Viatris

Erlotinib Viatris is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to cancer therapy.

Erlotinib Viatris is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' This medication is typically prescribed for advanced or metastatic forms of these cancers, where other treatments may not be as effective.

Common effects of Erlotinib Viatris may include skin rash, diarrhea, and fatigue. Some users may also experience appetite loss or nausea. These effects can vary in severity and may not affect everyone who takes the medication. It's important to monitor any changes in your health while using this drug.

Erlotinib Viatris should be handled with care, especially for those with pre-existing liver or kidney conditions. It is crucial to follow the advice of a healthcare professional regarding its use. Pregnant women or those planning to become pregnant should discuss the potential risks with their doctor before starting this medication.

Erlotinib Viatris may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, consuming alcohol while taking this medication may increase the risk of side effects.